Advancements in laboratory techniques for early cancer detection and monitoring
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233848Keywords:
Early cancer detection, Liquid biopsies, Advanced imaging, Genomic profiling, Personalized medicineAbstract
In years, there have been advancements in laboratory methods for detecting and monitoring cancer at its earliest stages. These breakthroughs have revolutionized the field of cancer care with a focus on treatment strategies. This review explores a range of laboratory-based approaches, including biopsies, advanced imaging technologies like PET, MRI, and CT scans, genomic profiling techniques such as next-generation sequencing novel biomarkers, innovative assay platforms, and the use of artificial intelligence-driven analytics. Liquid biopsies are particularly valuable as they provide real-time insights into tumor dynamics and responses to treatment by analyzing circulating tumor cells and cell-free DNA. Advanced imaging modalities offer enhanced sensitivity and resolution for the detection and monitoring of tumors. Genomic profiling techniques help unravel the complexities of tumors to guide therapies. Novel biomarkers show promise in types of cancer by aiding in screening prognosis determination and treatment monitoring. Innovative assay platforms allow for the analysis of biomarkers to improve diagnosis. The integration of intelligence (AI) and machine learning has been instrumental in interpreting clinical and molecular data alongside traditional laboratory techniques. However, despite progress made far challenges related to standardization, cost effectiveness, and ethical considerations persist. It is crucial to integrate these techniques into clinical practice to fully exploit their potential in enhancing cancer care.
References
Loud JT, Murphy J. Cancer Screening and Early Detection in the 21st Century. Semin Oncol Nurs. 2017;33(2):121-8.
Armakolas A, Kotsari M, Koskinas J. Liquid Biopsies, Novel Approaches and Future Directions. Cancers (Basel). 2023;15(5):1579.
Li S, Xin K, Pan S, Wang Y, Zheng J, Li Z, et al. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. Cell Mol Biol Lett. 2023;28(1):28.
Raphael BJ, Dobson JR, Oesper L, Vandin F. Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine. Genome Med. 2014;6(1):5.
Berger MF, Mardis ER. The emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol. 2018;15(6):353-65.
Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12(1):8.
Shegekar T, Vodithala S, Juganavar A. The Emerging Role of Liquid Biopsies in Revolutionising Cancer Diagnosis and Therapy. Cureus. 2023;15(8):e43650.
Roberto TM, Jorge MA, Francisco GV, Noelia T, Pilar RG, Andrés C. Strategies for improving detection of circulating tumor DNA using next generation sequencing. Cancer Treat Rev. 2023;119:102595.
Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RVL. Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep (Hoboken). 2023;6(2):e1764.
Liu CH, Grodzinski P. Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities. Radiol Imaging Cancer. 2021;3(3):e200052.
Santos DAR, Gaiteiro C, Santos M, Santos L, Dinis-Ribeiro M, Lima L. MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review. Int J Mol Sci. 2023;24(13):11023.
Staicu CE, Predescu DV, Rusu CM, Radu BM, Cretoiu D, Suciu N, et al. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview. Cells. 2020;9(1):169.
Wu X, Zhu L, Ma PC. Next-Generation Novel Noninvasive Cancer Molecular Diagnostics Platforms Beyond Tissues. Am Soc Clin Oncol Educ Book. 2018;38(38):964-77.
Hunter B, Hindocha S, Lee RW. The Role of Artificial Intelligence in Early Cancer Diagnosis. Cancers (Basel). 2022;14(6):1524.
Babayan A, Pantel K. Advances in liquid biopsy approaches for early detection and monitoring of cancer. Genome Med. 2018;10(1):21.
Houlihan CF, Whitworth JA. Outbreak science: recent progress in the detection and response to outbreaks of infectious diseases. Clin Med (Lond). 2019;19(2):140-4.
Yang J, Nittala MR, Velazquez AE, Buddala V, Vijayakumar S. An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series. Cureus. 2023;15(4):e37889.
Strianese O, Rizzo F, Ciccarelli M, Galasso G, D'Agostino Y, Salvati A, et al. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. Genes (Basel). 2020;11(7):747.
Liaropoulos I, Liaropoulos A, Liaropoulos K. Critical Assessment of Cancer Characterization and Margin Evaluation Techniques in Brain Malignancies: From Fast Biopsy to Intraoperative Flow Cytometry. Cancers (Basel). 2023;15(19):4843.
Haney K, Tandon P, Divi R, Ossandon MR, Baker H, Pearlman PC. The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary. IEEE J Transl Eng Health Med. 2017;5:2800514.
Smania MA. Liquid biopsy for cancer screening, diagnosis, and treatment. J Am Assoc Nurse Pract. 2020;32(1):5-7.
Dalle I, Jabbour E, Short NJ. Evaluation and management of measurable residual disease in acute lymphoblastic leukemia. Ther Adv Hematol. 2020;11:2040620720910023.
